Olema Pharmaceuticals Inc... (OLMA)
NASDAQ: OLMA
· Real-Time Price · USD
5.52
0.26 (4.94%)
At close: Aug 15, 2025, 3:59 PM
5.54
0.36%
After-hours: Aug 15, 2025, 06:03 PM EDT
Olema Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 364K | 364K | 364K | 1.88M | 1.88M | 1.88M | 1.88M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 405K | 499K | 459K | 365K | 360K | 691K | 1.03M | 1.36M | 1.69M | 1.68M | 1.66M | 2.81M | 2.44M | 2.06M | 1.66M | 90K | 40K | 9K |
Gross Profit | -41K | -135K | -95K | 1.52M | 1.52M | 1.19M | 854K | -1.36M | -1.69M | -1.68M | -1.66M | -2.81M | -2.44M | -2.06M | -1.66M | -90K | -40K | -9K |
Operating Income | -157.13M | -142.79M | -142.26M | -135.91M | -121.63M | -109.7M | -104.96M | -101.76M | -101.64M | -113.34M | -106.99M | -101.53M | -96.07M | -79.3M | -71.49M | -59.87M | -49.97M | -35.94M |
Interest Income | 14.79M | 13.85M | 12.68M | 12.94M | 11.93M | 10.37M | 8.32M | 5.75M | 4.45M | 3.31M | 2.23M | 1.36M | 847K | 549K | 442K | 334K | 252K | 168K |
Pretax Income | -142.29M | -128.89M | -129.47M | -122.68M | -109.63M | -99.34M | -96.66M | -96.06M | -97.28M | -110.04M | -104.79M | -100.25M | -95.24M | -78.79M | -71.1M | -59.59M | -49.72M | -35.77M |
Net Income | -142.29M | -128.89M | -129.47M | -122.68M | -109.63M | -99.34M | -95.34M | -93.71M | -94.42M | -107.19M | -103.02M | -99.52M | -95.02M | -78.56M | -71.1M | -59.59M | -49.72M | -35.77M |
Selling & General & Admin | 17.07M | 17.53M | 17.74M | 17.73M | 17.22M | 16.41M | 18.73M | 19.91M | 21.62M | 24.25M | 24.71M | 24.86M | 24.5M | 22.88M | 20.39M | 18.45M | 16.41M | 12.33M |
Research & Development | 140.05M | 125.26M | 124.52M | 118.09M | 104.32M | 93.2M | 86.14M | 81.85M | 80.03M | 89.09M | 82.27M | 76.67M | 71.56M | 56.42M | 51.1M | 41.41M | 33.56M | 23.6M |
Other Expenses | n/a | n/a | 17K | 110K | 31K | -13K | -19K | -45K | -86K | -22K | -27K | -84K | -20K | -41K | -47K | -57K | n/a | 1K |
Operating Expenses | 157.13M | 142.79M | 142.26M | 135.82M | 121.54M | 109.61M | 104.87M | 101.76M | 101.64M | 113.34M | 106.99M | 101.53M | 96.07M | 79.3M | 71.49M | 59.87M | 49.97M | 35.94M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | -88K | -88K | -88K | -88K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 157.31M | 142.97M | 142.44M | 135.91M | 121.63M | 109.7M | 104.96M | 101.76M | 101.64M | 113.34M | 106.99M | 101.53M | 96.07M | 79.3M | 71.49M | 59.87M | 49.97M | 35.94M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -1.32M | -2.36M | -2.86M | -2.86M | -1.77M | -789K | -343K | -344K | -9K | 54K | 111K | 112K |
Shares Outstanding (Basic) | 85.5M | 85.43M | 58.74M | 57.26M | 56.28M | 55.57M | 54.78M | 44.98M | 40.72M | 40.35M | 40.19M | 40.04M | 39.92M | 39.83M | 39.74M | 39.61M | 39.42M | 39.33M |
Shares Outstanding (Diluted) | 85.5M | 85.43M | 58.74M | 57.26M | 56.28M | 55.57M | 54.78M | 44.98M | 40.72M | 40.35M | 40.19M | 40.04M | 39.92M | 39.83M | 39.74M | 39.61M | 39.42M | 39.33M |
EPS (Basic) | -2.04 | -2.07 | -2.27 | -2.19 | -2.07 | -2.02 | -2.13 | -2.27 | -2.34 | -2.67 | -2.57 | -2.48 | -2.38 | -1.98 | -1.8 | -1.76 | -1.52 | -1.27 |
EPS (Diluted) | -2.04 | -2.07 | -2.27 | -2.19 | -2.07 | -2.02 | -2.13 | -2.27 | -2.34 | -2.67 | -2.57 | -2.48 | -2.38 | -1.98 | -1.8 | -1.76 | -1.52 | -1.27 |
EBITDA | -156.79M | -142.36M | -141.87M | -135.54M | -121.27M | -109.33M | -104.68M | -101.48M | -101.36M | -113.06M | -106.63M | -101.07M | -95.66M | -78.94M | -71.21M | -59.77M | -49.9M | -35.86M |
EBIT | -153.05M | -142.79M | -142.26M | -135.91M | -121.63M | -109.7M | -104.96M | -101.76M | -101.64M | -113.34M | -106.99M | -101.41M | -95.95M | -79.18M | -71.37M | -59.87M | -49.95M | -35.88M |
Depreciation & Amortization | 339K | 433K | 393K | 365K | 360K | 691K | 1.03M | 1.36M | 1.69M | 1.68M | 1.66M | 2.81M | 2.44M | 2.06M | 1.66M | 94K | 46K | 17K |